307 related articles for article (PubMed ID: 1733808)
1. Glucose transporter levels in tissues of spontaneously diabetic Zucker fa/fa rat (ZDF/drt) and viable yellow mouse (Avy/a).
Slieker LJ; Sundell KL; Heath WF; Osborne HE; Bue J; Manetta J; Sportsman JR
Diabetes; 1992 Feb; 41(2):187-93. PubMed ID: 1733808
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of muscle glucose transporter GLUT-4 in diabetic fatty Zucker rats (ZDF/Drt-fa).
Friedman JE; de Venté JE; Peterson RG; Dohm GL
Am J Physiol; 1991 Dec; 261(6 Pt 1):E782-8. PubMed ID: 1767839
[TBL] [Abstract][Full Text] [Related]
3. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
[TBL] [Abstract][Full Text] [Related]
4. Failure of insulin-regulated recruitment of the glucose transporter GLUT4 in cardiac muscle of obese Zucker rats is associated with alterations of small-molecular-mass GTP-binding proteins.
Uphues I; Kolter T; Goud B; Eckel J
Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):161-6. PubMed ID: 7575448
[TBL] [Abstract][Full Text] [Related]
5. Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in type 1 and type 2 rat diabetic models.
Villanueva-Peñacarrillo ML; Puente J; Redondo A; Clemente F; Valverde I
Endocrine; 2001 Jul; 15(2):241-8. PubMed ID: 11720253
[TBL] [Abstract][Full Text] [Related]
6. v- and t-SNARE protein expression in models of insulin resistance: normalization of glycemia by rosiglitazone treatment corrects overexpression of cellubrevin, vesicle-associated membrane protein-2, and syntaxin 4 in skeletal muscle of Zucker diabetic fatty rats.
Maier VH; Melvin DR; Lister CA; Chapman H; Gould GW; Murphy GJ
Diabetes; 2000 Apr; 49(4):618-25. PubMed ID: 10871200
[TBL] [Abstract][Full Text] [Related]
7. Effects of type-2 diabetes and troglitazone on the expression patterns of small intestinal sugar transporters and PPAR-gamma in the Zucker diabetic fatty rat.
Corpe C; Sreenan S; Burant C
Digestion; 2001; 63(2):116-23. PubMed ID: 11244250
[TBL] [Abstract][Full Text] [Related]
8. Suppression of GLUT4 expression in skeletal muscle of rats that are obese from high fat feeding but not from high carbohydrate feeding or genetic obesity.
Kahn BB; Pedersen O
Endocrinology; 1993 Jan; 132(1):13-22. PubMed ID: 8419118
[TBL] [Abstract][Full Text] [Related]
9. Glycemia and exercise training alter glucose transport and GLUT4 in the Zucker rat.
Sherman WM; Friedman JE; Gao JP; Reed MJ; Elton CW; Dohm GL
Med Sci Sports Exerc; 1993 Mar; 25(3):341-8. PubMed ID: 8455449
[TBL] [Abstract][Full Text] [Related]
10. Cardiac and skeletal muscle fatty acid transport and transporters and triacylglycerol and fatty acid oxidation in lean and Zucker diabetic fatty rats.
Bonen A; Holloway GP; Tandon NN; Han XX; McFarlan J; Glatz JF; Luiken JJ
Am J Physiol Regul Integr Comp Physiol; 2009 Oct; 297(4):R1202-12. PubMed ID: 19675275
[TBL] [Abstract][Full Text] [Related]
11. Effects of estradiol, estrogen receptor subtype-selective agonists and genistein on glucose metabolism in leptin resistant female Zucker diabetic fatty (ZDF) rats.
Weigt C; Hertrampf T; Flenker U; Hülsemann F; Kurnaz P; Fritzemeier KH; Diel P
J Steroid Biochem Mol Biol; 2015 Nov; 154():12-22. PubMed ID: 26134426
[TBL] [Abstract][Full Text] [Related]
12. Liver and muscle-fat type glucose transporter gene expression in obese and diabetic rats.
Yamamoto T; Fukumoto H; Koh G; Yano H; Yasuda K; Masuda K; Ikeda H; Imura H; Seino Y
Biochem Biophys Res Commun; 1991 Mar; 175(3):995-1002. PubMed ID: 2025268
[TBL] [Abstract][Full Text] [Related]
13. Evolution of metabolic and renal changes in the ZDF/Drt-fa rat model of type II diabetes.
Vora JP; Zimsen SM; Houghton DC; Anderson S
J Am Soc Nephrol; 1996 Jan; 7(1):113-7. PubMed ID: 8808117
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance in obese Zucker rat (fa/fa) skeletal muscle is associated with a failure of glucose transporter translocation.
King PA; Horton ED; Hirshman MF; Horton ES
J Clin Invest; 1992 Oct; 90(4):1568-75. PubMed ID: 1401086
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes.
Leonard BL; Watson RN; Loomes KM; Phillips AR; Cooper GJ
Acta Diabetol; 2005 Dec; 42(4):162-70. PubMed ID: 16382303
[TBL] [Abstract][Full Text] [Related]
16. Comparison of tissue metal concentrations in Zucker lean, Zucker obese, and Zucker diabetic fatty rats and the effects of chromium supplementation on tissue metal concentrations.
Staniek H; Rhodes NR; Di Bona KR; Deng G; Love ST; Pledger LA; Blount J; Gomberg E; Grappe F; Cernosek C; Peoples B; Rasco JF; Krejpcio Z; Vincent JB
Biol Trace Elem Res; 2013 Mar; 151(3):373-83. PubMed ID: 23250541
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of GLUT1 and GLUT4 glucose transporters in skeletal muscle of a new model of type II diabetes. The obese SHR/N-cp rat.
Marette A; Atgié C; Liu Z; Bukowiecki LJ; Klip A
Diabetes; 1993 Aug; 42(8):1195-201. PubMed ID: 8325452
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker-ZDF rats.
Liu X; Pérusse F; Bukowiecki LJ
Am J Physiol; 1998 May; 274(5):R1212-9. PubMed ID: 9644032
[TBL] [Abstract][Full Text] [Related]
19. Analysis of gene expression profiles in insulin-sensitive tissues from pre-diabetic and diabetic Zucker diabetic fatty rats.
Suh YH; Kim Y; Bang JH; Choi KS; Lee JW; Kim WH; Oh TJ; An S; Jung MH
J Mol Endocrinol; 2005 Apr; 34(2):299-315. PubMed ID: 15821098
[TBL] [Abstract][Full Text] [Related]
20. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
Wasan KM; Risovic V; Yuen VG; McNeill JH
J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
